Pancreatic Cancer Research

ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years

Xianghan Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4686-7756; OpenAlex author ID A5083336930. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 2 papers · 2025: 2 papers

Papers 4

  1. hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.217436↗
  2. HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.2174/1566523223666230720101531↗
  3. Expression landscape of cancer-FOXP3 and its prognostic value in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.216838↗
  4. hnRNPAB Promotes Pancreatic Ductal Adenocarcinoma Extravasation and Liver Metastasis by Stabilizing MYC mRNA. Co-author DOI 10.1158/1541-7786.mcr-24-0110↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ke Lei · 4 shared papers, 2024–2025 · strength 0.90
  2. Ruining Gong · 4 shared papers, 2024–2025 · strength 0.90
  3. He Ren · 4 shared papers, 2024–2025 · strength 0.90
  4. Qian Yu · 2 shared papers, 2025 · strength 0.51
  5. Jigang Wang · 2 shared papers, 2024–2025 · strength 0.44
  6. Boyi Ma · 1 shared paper, 2025 · strength 0.27
  7. Ashok Kumar Saluja · 1 shared paper, 2025 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.